Skip to main content
MedVellum
MCQsExamsAtlas
DashboardPricing
MBBS / Core medicine✳Dermatology✳ICU Fellowship (CICM)✳Anaesthesia✳Emergency Medicine✳Psychiatry Fellowship✳Paediatrics Fellowship✳Physician Medicine✳MCQs✳SAQs✳Vivas✳OSCE✳Evidence-first✳MBBS / Core medicine✳Dermatology✳ICU Fellowship (CICM)✳Anaesthesia✳Emergency Medicine✳Psychiatry Fellowship✳Paediatrics Fellowship✳Physician Medicine✳MCQs✳SAQs✳Vivas✳OSCE✳Evidence-first✳

MedVellum.

The folio

Exam-exhaustive medical education across every specialty — evidence-graded topics, engraved plates, and practice in every written and oral format. Educational content only — not medical advice.

llms.txt · psychiatry LLM catalog · sitemap

Atlas

  • Specialty atlas
  • MBBS / Core medicine
  • Dermatology
  • ICU Fellowship (CICM)
  • Anaesthesia
  • Emergency Medicine
  • Psychiatry Fellowship
  • Paediatrics Fellowship
  • Physician Medicine

Study & account

  • MCQ practice
  • Practice alias
  • Exam tools
  • Dashboard
  • Pricing
  • Sign in

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

Folio edition · Set in Instrument Serif & Archivo

Paeds Casespaediatric-dermatology

Paeds Cases · paediatric-dermatology

Tinea and fungal skin infection — structured clinical encounter

Structured encounter testing the approach to a five-year-old with a scaly bald scalp patch and broken hair stubs: the recognition of tinea capitis, the species-guided oral therapy with terbinafine or griseofulvin, household carrier screening, the avoidance of tinea incognito, and a pivot to a four-year-old with a painful boggy kerion after contact with a kitten.

structured clinical encounter
On this page & tools

Target exams

RACP General PaediatricsRACP DCEMRCPCH ClinicalRCPSC Pediatrics

Target exams

RACP General PaediatricsRACP DCEMRCPCH ClinicalRCPSC Pediatrics
Prompt
A five-year-old boy presents with a three-week history of an itchy, scaly, gradually enlarging bald patch on the scalp with broken hair stubs, black dots flush with the skin, mild scaling and a firm enlarged occipital lymph node. You are the paediatric registrar working through assessment, confirmation, the species-guided oral therapy, household carrier screening, the avoidance of tinea incognito, and a later scenario of a painful boggy kerion in a four-year-old after contact with a kitten.

Station 1 — recognition and confirmation

Asked for my first impression, I would recognise this as tinea capitis. The broken hair stubs and the black dots flush with the scalp are hair broken off at the surface, the endothrix pattern typical of Trichophyton tonsurans, and the enlarged occipital node favours a fungal scalp infection over a non-infectious dermatosis such as alopecia areata, which is smooth and non-scaly with exclamation-mark hairs and no nodes. I would confirm with potassium hydroxide microscopy of a plucked hair looking for branching septate hyphae and arthroconidia, and send fungal culture to identify the species. [1]

Station 2 — the oral-therapy principle

Asked how I would treat it, I would state that tinea capitis always needs an oral antifungal because the fungus lives inside the hair shaft and a topical cream cannot penetrate the follicle. A topical alone would fail, the hair loss would continue, and the child would keep spreading spores. I would therefore start an oral agent — griseofulvin or terbinafine, guided by the species — rather than a cream. [2]

Station 3 — the species-guided drug choice

Asked which drug for a confirmed Trichophyton tonsurans in a 22 kg child, I would choose terbinafine. The meta-analyses show terbinafine is superior for Trichophyton species and griseofulvin is superior for Microsporum species. Using the weight bands of 62.5 mg daily under 20 kg, 125 mg daily for 20 to 40 kg and 250 mg daily over 40 kg, a 22 kg child takes 125 mg daily for 4 weeks. If the organism were Microsporum I would switch to griseofulvin at 10 mg/kg/day microsize for 6 to 8 weeks, because griseofulvin is superior for that genus. [4] [5]

Station 4 — household carrier screening

Asked how I would prevent recurrence, I would explain that recurrence after an adequate oral course almost always reflects an untreated reservoir: asymptomatic scalp carriage in household contacts and an untreated pet. I would screen and treat the family contacts, use an antifungal shampoo such as ketoconazole to reduce spore shedding, and have a veterinarian examine any pets. For a zoophilic organism I would specifically ask about kittens and puppies as the source, because an untreated animal will reinfect the treated child within weeks. [10]

Station 5 — the kerion and the steroid pitfall

Finally I describe how I would handle a four-year-old with a painful, boggy, purulent, inflamed scalp mass two weeks after the family acquired a kitten. I would recognise this as a kerion, an intense delayed hypersensitivity reaction to a zoophilic dermatophyte, most likely Microsporum canis. I would start an oral antifungal immediately and add a short tapering course of oral corticosteroid to reduce the inflammation and the risk of permanent scarring alopecia, and I would explicitly avoid incision and drainage because the pus is inflammatory rather than a drainable bacterial abscess. I would also warn against using a topical corticosteroid on any unrecognised scaly annular lesion, because it produces tinea incognito: it suppresses the border and itch while allowing unchecked fungal spread, leaving an atrophic, pustular lesion that is harder to recognise and to treat. [1] [2] [6]

References

  1. [1]Gupta AK, Polla Ravi S, Wang T, et al. An update on tinea capitis in children. Pediatr Dermatol, 2024.PMID 39113245
  2. [2]Fuller LC, Barton RC, Mohd Mustapa MF, et al. British Association of Dermatologists' guidelines for the management of tinea capitis 2014. Br J Dermatol, 2014.PMID 25234064
  3. [4]Tey HL, Tan AS, Chan YC Meta-analysis of randomized, controlled trials comparing griseofulvin and terbinafine in the treatment of tinea capitis. J Am Acad Dermatol, 2011.PMID 21334096
  4. [5]Gupta AK, Drummond-Main C Meta-analysis of randomized, controlled trials comparing particular doses of griseofulvin and terbinafine for the treatment of tinea capitis. Pediatr Dermatol, 2013.PMID 22994156
  5. [6]Leung AK, Lam JM, Leong KF, et al. Tinea corporis: an updated review. Drugs Context, 2020.PMID 32742295
  6. [10]Dessinioti C, Papadogeorgaki E, Athanasopoulou V, et al. Screening for asymptomatic scalp carriage in household contacts of patients with tinea capitis during 1997-2011: a retrospective hospital-based study. Mycoses, 2014.PMID 24372570